UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                  SCHEDULE 13G

                   Under the Securities Exchange Act of 1934
                               (Amendment No.  )*

                            Meris Laboratories Inc.
                                (Name of Issuer)

                                  Common Stock
                         (Title of Class of Securities)

                                   589848100
                                 (CUSIP Number)

*The remainder of this cover shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsquenent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

1.  NAME OF REPORTING PERSON
    S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
        Morton H. Sachs & Co. DBA The Sachs Company

2.  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                     (a)
        N/A                                                               (b)

3.  SEC USE ONLY

4.  CITIZENSHIP OR PLACE OF ORGANIZATION
        Kentucky

NUMBER OF               5.  SOLE VOTING POWER                       841,500
SHARES
BENEFICIALLY            6.  SHARED VOTING POWER                           0
OWNED BY
EACH                    7.  SOLE DISPOSITIVE POWER                  841,500
REPORTING PERSON
WITH                    8.  SHARED DISPOSITIVE POWER                      0

9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
        841,500

10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
        N/A

11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
        10.5%

12. TYPE OF REPORTING PERSON*
        IA







Cusip No.589848100                      13G                   Page 2 of 3 Pages

Schedule 13G Additional Information

Item #
1. (a)  Name of Issuer:
         Meris Laboratories Inc.

   (b)  Address of Issuer's Principal Executive Offices:
         2890 Zanker Road
         San Jose, CA  95134

2. (a)  Name of Person Filing:
         Morton H. Sachs & Co. DBA The Sachs Company

   (b)  Address of Principal Business Office for Each of the Above:
         1346 South Third Street
         Louisville, KY  40208

   (c)  Citizenship:
         A Kentucky Corporation

   (d)  Title of  Class of  Securities:
         Common Stock

   (e)  CUSIP Number:
         589848100

3. This statement is filed pursuant to Rule 13d-1(b), or 13d-2(b).  The 
   person filing is a:
   (a) [ ] Broker or Dealer registered under Section 15 of the Act
   (b) [ ] Bank as defined in section 3(a)(6) of the Act
   (c) [ ] Insurance Company as defined in section 3(a)(19) of the Act
   (d) [ ] Investment Company registered under section 8 of the Investment 
           Company Act
   (e) [x] Investment Adviser registered under section 203 of the Investment 
           Advisers Act of 1940
   (f) [ ] Employee Benefit Plan, Pension Fund which is subject to the 
           provsions of the Employee Retirement Income Security Act of 1974 or 
           Endowment Fund
   (g) [ ] Parent Holding Company, in accordance with 240.13d-1(b)(ii)(G) 
           (Note: See Item 7) The Sachs Company is an investment adviser 
           registered under Section 203 of the Investment Advisers Act of 
           1940 and Morton H. Sachs is an individual controlling shareholder 
           thereof reporting under Rule 13d-1(b) (ii) (G).
   (h) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(H)

4. Ownership:
   (a) Amount Beneficially Owned:                                      841,500
   (b) Percent of Class:                                                  10.5%
   (c) Number of shares as to which such person has:
        (i)   sole power to vote or to direct the vote                 841,500 
        (ii)  shared power to vote or to direct the vote                None  
        (iii) sole power to dispose or to direct the disposition of    841,500  
        (iv)  shared power to dispose or to direct the disposition of   None

5. Ownership of Five Percent or Less of a Class:
         N/A







CUSIP NO.589848100                      13G                   Page 3 of 3 Pages


Schedule 13G Additional Information  (continued)

Item #
6.  Ownership of More than Five Percent on Behalf of Another Person:
            N/A

7.  Identification and Classification of the Subsidiary Which Acquired the 
    Security Being Reported on by the Parent Holding Company:
            N/A

8.  Identification and Classification of Members of the Group:
            N/A

9.  Notice of Dissolution of  Group:
            N/A

10. Certification:

            By signing below, the undersigned certifies that, to the best of 
            its knowledge and belief, the securities referred to above were 
            acquired in the ordinary course of business and were not acquired 
            for the purpose of and do not have the effect of changing or
            influencing the control of the  issuer of such securities and were 
            not acquired in connection with or as a participant in any 
            transaction having such purpose or effect.

            SEE NOTE No. 1 BELOW

            After reasonable inquiry and to the best of my knowledge and 
            belief, I certify that the information set forth in this statement 
            is true, complete and correct.

Dated:      As of June 10, 1996


Signature:  Dated On: February 12, 1997
            Morton H. Sachs, President
            Morton H. Sachs & Co. DBA The Sachs Company
            By /s/ Morton H. Sachs

NOTE No. 1: The reporting person hereby disclaims beneficial ownership of the
            above shares, and the filing of this statement shall not be 
            construed as an admission that the reporting person is the 
            beneficial owner of the shares covered by this statement.